Medicare AdvantageCoverageMedium impact
MA00.004b, Routine Costs of Clinical Trials and Coverage of Investigational Devices A and B
Independence Blue Cross·Oncology·Medical Policy
Effective date
Nov 26, 2025
We identified it
Jun 19, 2026
Summary
Policy MA00.004b has been reissued effective 11/26/2025 regarding routine costs of clinical trials and coverage of investigational devices A and B. This is a recent Medicare Advantage policy update that may affect billing for clinical trial participation and investigational device coverage. The full policy details are not provided in this submission, so specific billing impacts cannot be determined without access to the complete policy text.
Action Required
By 11/26/2025: Billing team must obtain and review the complete policy text from https://medpolicy.ibx.com/ibc/ma/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=11&FilterField2=MPSiteActivityLogYear&FilterValue2=2025#medicare-advantage-ma00-004b-routine-costs-of-clinical-trial. Identify any clinical trial billing codes used at this practice and determine if coverage rules, prior authorization requirements, or billing procedures have changed. Update billing software, encounter forms, and provider education materials accordingly before the effective date. Notify clinical trial coordinators and providers of any changes to routine cost billing or investigational device coverage policies to prevent claim denials.